Table 1Key Questions from Comparative Effectiveness Review

KQ 1In patients receiving intensive insulin therapy, does mode of delivery (MDI vs. CSII) have a differential effect on process measures, intermediate outcomes, and clinical outcomes in patients with diabetes mellitus?
KQ 2In patients using intensive insulin therapy (MDI or CSII), does the type of glucose monitoring (rt-CGM vs. SMBG) have a differential effect on process measures, intermediate outcomes, and clinical outcomes in patients with diabetes mellitus (i.e., what is the incremental benefit of rt-CGM in patients already using intensive insulin therapy)?

Abbreviations: KQ = Key Question; CSII = continuous subcutaneous insulin infusion; MDI = multiple daily injections; rt-CGM = Real-time continuous glucose monitoring; SMBG = Self-monitoring of blood glucose

From: Background

Cover of Insulin Delivery and Glucose Monitoring Methods: Future Research Needs
Insulin Delivery and Glucose Monitoring Methods: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 57 [Internet].
Future Research Needs Papers, No. 32.
Yeh HC, Lau BD, Golden SH, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.